Clinical Trials Browser

Completed × Advanced Solid Tumor × spartalizumab × Clear all

NCT03874897 2024-04-30

Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumor